Lauren Santye, Assistant Editor

Alemtuzumab treats relapsing forms of multiple sclerosis, but is accompanied with a 50% risk of secondary autoimmune diseases.

A next generation sequencing test to detect lung cancer mutation was also approved.

Review suggests that low doses of multiple blood pressure drugs may be more effective than a standard dose of only 1 medication.

Dabrafenib and trametinib approved for patients with metastatic non-small cell lung cancer with BRAF V600E mutation.

Top news of the day from across the health care landscape.

Rituximab and hyaluronidase human approved for the treatment of adults with follicular lymphoma, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia.

Patients with HIV-associated sensory neuropathy have a decrease in corneal nerve fiber density and an increase in corneal nerve tortuosity.

Could household pets be the key to treating breast carcinoma?

Restoring a tumor suppressing gene offers a promising therapeutic target for diffuse intrinsic pontine glioma.

Onions contain one of the highest concentrations of quercetin, a flavonoid extract with anti-proliferative effects.

Top news of the day from across the health care landscape.

The high cost of treatment causes some payers to question coverage for these conditions.

Hurdles remain in adding college coursework dedicated to specialty pharmacy.

Comprehensive data collection in specialty pharmacy more important than ever.

New agents for vision conditions related to diabetes show promise, but come with challenges.

Tofacitinib and Guselkumab show promise in patients with PsA.

Cannabinoid treatment may alleviate some symptoms of multiple sclerosis and IBS, in addition to chemotherapy-induced nausea.

How NS5A inhibitors block hepatitis C virus replication impacts treatment outcomes.

Overutilization of care can produce disparities between high- and low-income counties.

Novel vaccine modulates T cell responses in RA.

Compounds found in turmeric, red grapes, and apple peels block cancer cells from accessing nutrients need to grow and survive.

Phase 3 study seeks to further understand the mechanisms of ocrelizumab.

Top news of the day from across the health care landscape.

Clearly defining a patient population is necessary to create a singular care framework.

A number of hurdles in HIV, including preventative efforts, still need to be addressed.

Achieving linkage to care and viral suppression among patients with HIV improves overall wellbeing and prevents new infections.

Publicly-funded cancer clinical trials are high impact and low cost, experts say.

Adcetris achieves superior outcomes in the treatment of CTCL.

Incidence of stroke was 2.17% per year in patients with cirrhosis compared with 1.11% in patients without cirrhosis.

Use of plant enzymes in bacterial cell factories may lead to effective anti-cancer drugs.